SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is seeing high community engagement driven by anticipation surrounding a potential IPO and end of conservatorship, spurred by the President's recent commentary regarding a trillion-dollar valuation for the GSEs. Investors are actively debating the timing of a potential re-listing, with discussions centered on recent analyst upgrades, the actions of high-profile investors like Bill Ackman and Michael Burry, and speculation about the impact of incoming leadership on the GSE framework.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing increased retail interest and active community discussion regarding its long-term potential as a key data provider for AI model training. While investors debate the stock's volatility and its relationship with the broader software sector, sentiment remains focused on the platform's ability to monetize its massive archive of human-generated content.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors await the upcoming earnings report, with community discussion centered on potential revenue growth, DefenCath adoption, and the impact of the pending CMS policy update. Shareholders are actively debating management's recent guidance and the long-term potential for expansion into oncology and TPN markets.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is experiencing a surge in community engagement and bullish sentiment following the official announcement that pre-orders for Grand Theft Auto VI will begin on June 25. Investors and gamers are closely watching this milestone as a key indicator of commercial momentum, with many on social media actively debating the potential for record-breaking sales and the stock's long-term growth trajectory leading up to the game's highly anticipated release.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge is seeing significant market interest as it shifts toward AI-driven data center power infrastructure and solid-state transformer technology, with investors reacting to earnings reports and broader solar sector volatility. The community remains heavily divided between those betting on a long-term turnaround fueled by new product cycles and those focused on bearish technical factors, including ongoing litigation settlements and concerns over the company's profitability and debt levels.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

The iShares Biotechnology ETF is trending as investors pivot into the sector, driven by a combination of clinical breakthroughs, robust M&A activity, and a broader small-cap market rotation. The community is actively debating whether this momentum represents the beginning of a sustainable new bull cycle or a temporary rally, while tracking potential acquisition targets and upcoming regulatory milestones for key companies within the sector.

Photronics, Inc. engages in the provision of photomasks, which are quartz or glass plates containing microscopic images of electronic circuits for use in the fabrication of integrated circuits and flat-panel displays. The company was founded by Constantine S. Macricostas in 1969 and is headquartered in Brookfield, CT.

Photronics, Inc.

Photronics is trending as investors digest the impact of its recent earnings miss and soft guidance, which triggered a significant short-term pullback in the stock. While some in the community view the current price as a deep-value opportunity given the company's strong balance sheet and role as a key photomask supplier for AI-driven chip demand, others are wary of the stock's recent technical weakness and the broader volatility across the semiconductor sector.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as the community eagerly anticipates pivotal data readouts at the upcoming ASH meeting, with investors closely watching potential synergy with Incyte for a possible buyout. The sentiment is bolstered by strong Revuforj performance and community belief that the company remains significantly undervalued compared to its oncology peers.

Vishay Intertechnology, Inc. engages in the manufacture and distribution of discrete semiconductors and passive electronic components. It operates through the following segments: MOSFET (metal oxide semiconductor field-effect transistor), Diodes, Optoelectronic Components, Resistors, Inductors, and Capacitors. The MOSFET segment offers semiconductors which function as solid state switches to control power. The Diodes segment produces semiconductors which route, regulate, and block radio frequency, analog, and power signals, protect systems from surges or electrostatic discharge damage, and provide electromagnetic interference filtering. The Optoelectronic Components segment includes components that emit light, detect light, or do both. The Resistors and Inductors segment deals with components that impede electric current. The Capacitors segment provides components which store energy and discharge it when needed. The company was founded by Felix Zandman in 1962 and is headquartered in Malvern, PA.

Vishay Intertechnology, Inc.

Vishay Intertechnology is generating significant buzz as it hits fresh 52-week highs, with the community highlighting its strategic position as a foundational supplier for AI infrastructure, robotics, and power management. Investors are actively debating the sustainability of its rapid ascent while tracking institutional accumulation and monitoring technical breakout levels amid broader semiconductor sector momentum.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is attracting community debate following a 1-for-10 reverse stock split and a strategic shift toward a more diversified portfolio of blue-chip and high-volatility holdings. Investors are actively discussing whether these structural changes and the transition toward NAV stability will successfully counteract previous erosion or if the fund remains a high-risk vehicle primarily for income harvesting.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 2, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost...

Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum

Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum PR Newswire NEW YORK, May 28, 2026 USA News Group News CommentaryIssued on behalf ofAva Bio, Inc.As...

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3% - Time to Sell?

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 7.3% - Here's What Happened...

Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell

Wall Street Zen lowered Sana Biotechnology from a "sell" rating to a "strong sell" rating in a research note on Saturday...

Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - What's Next?

Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - Here's Why...

Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the company, MarketBeat.com...

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up   - What's Next?

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - Here's What Happened...

Baillie Gifford & Co. Sells 4,827,438 Shares of Sana Biotechnology, Inc. $SANA

Baillie Gifford & Co. lessened its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 42.2% in the 4th quarter, according to the company in its most recent 13F filing with the...

Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday

Stock futures mixed, Citigroup and Wells Fargo report earnings, Sana Biotechnology announces collaboration.read more...

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

Equity

Sana on Monday inked a strategic collaboration with Mayo Clinic aimed at advancing the development of its investigational cell therapy SC451 for type 1 diabetes.


Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Sana Biotechnology Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.15	--	--	N/A
Q1 '26	-$0.16	-$0.17	-5.01%	MISSED
Q4 '25	-$0.14	-$0.21	-47.75%	MISSED
Q3 '25	-$0.19	-$0.16	15.23%	BEAT
Q2 '25	-$0.20	-$0.39	-94.27%	MISSED

SANASana Biotechnology Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest SANA News